Latest Stock/Share Market Updates | Corporate News | Announcements | BSE
Notices Media Release Trading Holidays BSEPlus Contact Us
हिन्दी     मराठी     ગુજરાતી


Latest Corporate Announcements

Announcement Type :   Search By :    
Security Name
Category
Date Calendar
To Date Calendar
Disclaimer  Next >>
   
Security Code : 532649    Company : NECTAR LIFESCIENCES LTD.
16 Aug 2017
Fixes Book Closure for Final Dividend & AGMAGM/EGMDownload PDF
  Exchange Disseminated Time     16/08/2017 11:57:56
Nectar Lifesciences Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 22, 2017 to September 28, 2017 (both days inclusive) for the purpose of Payment of Final Dividend & 22nd Annual General Meeting (AGM) of the Company to be held on September 28, 2017.
 
12 Aug 2017
Book Closure For AGM And Dividend.Corp. ActionDownload PDF
  Exchange Received Time  12/08/2017 16:36:52         Exchange Disseminated Time   12/08/2017 16:36:54              Time Taken   00:00:02
Register of Members and Share Transfer Books will remain closed from 22nd September, 2017 to 28th September 2017 (Both days inclusive) for the purpose of Annual General Meeting (AGM) and dividend, if any, declared by member in the AGM. Accordingly the cut of date, to ascertain the eligibility of members for remote e-voting and polling at AGM, is September 21, 2017 i.e. the date prior to the commencement of book closure.
 
Outcome of Board MeetingBoard MeetingDownload PDF
  Exchange Received Time  12/08/2017 13:19:14         Exchange Disseminated Time   12/08/2017 13:19:23              Time Taken   00:00:09
The Outcome of Board Meeting is attached.
 
Financial Results For The Quarter Ended June 30, 2017ResultDownload PDF
  Exchange Received Time  12/08/2017 13:12:33         Exchange Disseminated Time   12/08/2017 13:12:38              Time Taken   00:00:05
The Board of Directors of the Company at their meeting held today duly approved and took on record the limited reviewed Unaudited Standalone Financial results for the quarter ended June 30, 2017 which are enclosed herewith along with the Limited Review Report of the Auditors thereon.

This is for your information and record.
 
04 Aug 2017
  Notice Of Board Meeting To Be Held On Saturday, August 12, 2017 And Notice Of Trading WindowBoard MeetingDownload PDF
  Exchange Received Time  04/08/2017 15:20:51         Exchange Disseminated Time   04/08/2017 15:20:59              Time Taken   00:00:08
We wish to inform you that a meeting of the Board of Directors of the company will be held on Saturday August 12, 2017 to consider and approve, inter alia amongst items:

1. The Unaudited Financial Results of the Company for the Quarter ended on June 30, 2017.
2. To convene the Annual General Meeting of Members of the Company for the financial year 2016-17 and matters related thereto. ....
06 Jul 2017
Shareholding for the Period Ended June 30, 2017Company Update 
  Exchange Disseminated Time     06/07/2017 16:50:04
Nectar Lifesciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2017. For more details, kindly Click here
 
05 Jul 2017
Statement Of Investor Complaints For The Quarter Ended On June 30, 2017Company UpdateDownload PDF
  Exchange Received Time  05/07/2017 15:14:12         Exchange Disseminated Time   05/07/2017 15:14:16              Time Taken   00:00:04
Pursuant to Regulation 13(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Statement of Investor Complaints for the Quarter ended June 30, 2017 is attached.
 
27 Jun 2017
Board recommends Final DividendCorp. ActionDownload PDF
  Exchange Disseminated Time     27/06/2017 13:27:30
Nectar Lifesciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 27, 2017, inter alia, have recommended the 5% Final Dividend i.e. Re. 0.05/- per equity share to the members of the company, out of profits of the company for the financial year 2016-2017, subject to the approval of the members in their Annual General Meeting.
 
  Outcome of Board MeetingBoard MeetingDownload PDF
  Exchange Received Time  27/06/2017 13:21:31         Exchange Disseminated Time   27/06/2017 13:21:34              Time Taken   00:00:03
Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors in their meeting held on June 27, 2017 have recommended the 5% Final Dividend i.e. Re. 0.05/- per equity share to the members of the company, out of profits of the company for the financial year 2016-2017, subject to the approval of the members in their Annual General Meeting. ....
Audited Financial Results (Standalone And Consolidated) For The Period Ended On March 31, 2017ResultDownload PDF
  Exchange Received Time  27/06/2017 13:17:39         Exchange Disseminated Time   27/06/2017 13:17:43              Time Taken   00:00:04
Pursuant to captioned Regulation, please find enclosed herewith a copy of the Audited Financial Results (Standalone and Consolidated) for the period ended on March 31, 2017, as approved by the Board of Directors in their meeting held on even date i.e. June 27, 2017. A copy of the Auditor's Report is also enclosed herewith for your record please. The declaration that audit reports do not contain any modified opinion is also attached.
 
21 Jun 2017
  Notice Of Adjourned Board Meeting To Be Held On June 27, 2017.Board MeetingDownload PDF
  Exchange Received Time  21/06/2017 12:22:49         Exchange Disseminated Time   21/06/2017 12:22:55              Time Taken   00:00:06
We wish to inform you that the adjourned meeting of the Board of Directors of the company will be held on Tuesday, June 27, 2017 to consider and approve, inter alia amongst items:

1. The Audited Financial Results for the Financial Year 2016-17, Financial Statements of the Company for the Financial Year 2016-17 and matters related thereto. ....
30 May 2017
Outcome of Board MeetingBoard MeetingDownload PDF
  Exchange Received Time  30/05/2017 16:55:27         Exchange Disseminated Time   30/05/2017 16:55:28              Time Taken   00:00:01
Outcome and Adjournment of Audit Committee and Board of Directors Meeting.

 
26 May 2017
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011Insider Trading / SASTDownload PDF
  Exchange Disseminated Time     26/05/2017 12:54:03
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sanjiv HUF
 
23 May 2017
  Board to consider Final DividendCorp. ActionDownload PDF
  Exchange Disseminated Time     23/05/2017 11:39:01
Nectar Lifesciences Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 30, 2017, inter alia, to consider and approve :

1. The Audited Financial Results for the Financial Year 2016-17, Financial Statements of the Company for the Financial Year 2016-17 and matters related thereto.

2. Recommendation of final dividend to the Members of the Company for Financial Year 2016-17. ....
  Notice Of Board Meeting Meeting To Be Held On May 30, 2017 To Consider Audited Financial Results For The Quarter And Year Ended On March 31, 2017 And To Recommend Final Dividend And Closure Of Trading Window. Board MeetingDownload PDF
  Exchange Received Time  23/05/2017 11:32:52         Exchange Disseminated Time   23/05/2017 11:32:55              Time Taken   00:00:03
We wish to inform you that a meeting of the Board of Directors of the company will be held on Tuesday 30th May, 2017 to consider and approve, inter alia,: 1. The Audited Financial Results for the Financial Year 2016-17, Financial Statements of the Company for the Financial Year 2016-17 and matters related thereto. 2. Recommendation of final dividend to the Members of the company for Financial Year 2016-17. Further, pursuant to ....
11 May 2017
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011Insider Trading / SASTDownload PDF
  Exchange Disseminated Time     11/05/2017 13:25:34
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sanjiv Goyal
 
24 Apr 2017
Disclosures under Reg. 10(7) of SEBI (SAST) Regulations, 2011Insider Trading / SASTDownload PDF
  Exchange Disseminated Time     24/04/2017 16:43:35
The Exchange has received the disclosure under Regulation 10(7) in respect of acquisition under Regulation 10(1)(a)(ii)of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sanjiv HUF
 
10 Apr 2017
Compliance Certificate For The Period Ended On March 31, 2017.Company UpdateDownload PDF
  Exchange Received Time  10/04/2017 16:46:32         Exchange Disseminated Time   10/04/2017 16:46:37              Time Taken   00:00:05
Compliance certificate for the half year ended on March 31, 2017 as per regulation 7(3) of the Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
 
08 Apr 2017
Shareholding for the Period Ended March 31, 2017Company Update 
  Exchange Disseminated Time     08/04/2017 11:51:51
Nectar Lifesciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2017. For more details, kindly Click here
 
05 Apr 2017
Compliance Under Regulation 40(10) Of The Securities Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.Company UpdateDownload PDF
  Exchange Received Time  05/04/2017 17:36:30         Exchange Disseminated Time   05/04/2017 17:36:37              Time Taken   00:00:07
Nectar Lifesciences Limited - submission of compliance under Regulation 40(10) of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
 

Disclaimer Next >>